StockDuty ← Dashboard Jul 16, 2026 02:52 PM ET
CatalystFDA/Bio

MERCK'S CHOLESTEROL PILL LIPFENDRA GETS U.S. FDA APPROVAL - CNBC

FDA approval for Merck's new cholesterol drug Lipfendra signals major regulatory catalyst.

What changed
Why it matters
FDA approval for Merck's new cholesterol drug Lipfendra signals major regulatory catalyst.
Sources
cnbc
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →